OneMedNet Corp (ONMDW) stock
ONMDWNasdaqServices-Commercial Physical & Biological ResearchFiscal year ends December 31Also trades as ONMD
$0.02+0.00 (0.00%)
Close on Oct 30, 2026Market cap $250.19MP/E –Yield –
OneMedNet r&d expenses
Research and development expenses are spending on new products and technology.
OneMedNet's R&D Expenses for the twelve months ending Jun 30, 2026 was $1.40M, up 2.4% year over year. For fiscal 2025 it was $1.52M, up 3.3% from the year before.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.52M | +3.3% |
| FY2024 | Dec 31, 2024 | $1.47M | -29.0% |
| FY2023 | Dec 31, 2023 | $2.07M | +29.8% |
| FY2022 | Dec 31, 2022 | $1.59M | – |
Quarterly r&d expenses
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $324.00K | -15.2% |
| Q1 FY2026 | Mar 31, 2026 | $311.00K | -10.6% |
| Q4 FY2025 | Dec 31, 2025 | $443.00K | +30.3% |
| Q3 FY2025 | Sep 30, 2025 | $323.00K | +8.4% |
| Q2 FY2025 | Jun 30, 2025 | $382.00K | -0.3% |
| Q1 FY2025 | Mar 31, 2025 | $348.00K | -21.8% |
| Q4 FY2024 | Dec 31, 2024 | $340.00K | -31.9% |
| Q3 FY2024 | Sep 30, 2024 | $298.00K | -26.4% |
| Q2 FY2024 | Jun 30, 2024 | $383.00K | -33.9% |
| Q1 FY2024 | Mar 31, 2024 | $445.00K | -23.5% |
| Q4 FY2023 | Dec 31, 2023 | $499.00K | -43.3% |
| Q3 FY2023 | Sep 30, 2023 | $405.00K | – |
| Q2 FY2023 | Jun 30, 2023 | $579.00K | – |
| Q1 FY2023 | Mar 31, 2023 | $582.00K | – |
| Q4 FY2022 | Dec 31, 2022 | $880.64K | – |